Pharmaceutical

AbbVie and Umoja to develop new CAR-T therapies for cancer

AbbVie and Umoja Biopharma partnered for the development of in-situ CAR-T cell therapy candidates for oncology targets.

Jan 5, 2024 - 18:00
AbbVie and Umoja to develop new CAR-T therapies for cancer
AbbVie and Umoja Biopharma partnered for the development of in-situ CAR-T cell therapy candidates for oncology targets.
Read the original article

Tags:

Previous Article

MOMA Therapeutics and Roche sign cancer drug discovery deal

Next Article

Pharmaceutical Technology Excellence Awards 2023: KAI Conversations

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Biotech execs say IRA is causing unintended effects for cancer drug development

Biotech execs say IRA is causing unintended effects for...

Feb 28, 2024

AI will severely impact almost a fifth of jobs, Indeed says

AI will severely impact almost a fifth of jobs, Indeed ...

Oct 21, 2023

PTC Therapeutics gets grant for treatment of huntington...

Mar 30, 2024